Old Web
English
Sign In
Acemap
>
authorDetail
>
Martha Lugiollo
Martha Lugiollo
CD8
Medicine
Dendritic cell
FOXP3
Immunology
2
Papers
18
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A first-in-class, first-in-human, phase I trial of CIGB-552, a synthetic peptide targeting COMMD1 to inhibit the oncogenic activity of NF-κB in patients with advanced solid tumors.
2021
International Journal of Cancer
Maribel G. Vallespi
Braulio Mestre
María A Marrero
Rolando Uranga
Diana Rey
Martha Lugiollo
Mircea Betancourt
Kirenia Silva
Danay Corrales
Yanet Lamadrid
Yamilka Rodriguez
Anaelys Maceo
Pedro P Chaviano
Gilda Lemos
Ania Cabrales
Freya Freyre
Héctor Santana
Hilda Garay
Brizaida Oliva
Julio R. Fernández
Show All
Source
Cite
Save
Citations (0)
Nimotuzumab Induces NK Cell Activation, Cytotoxicity, Dendritic Cell Maturation and Expansion of EGFR-Specific T Cells in Head and Neck Cancer Patients
2017
Frontiers in Pharmacology
Zaima Mazorra
Anabel Lavastida
Fernando Concha-Benavente
Anet Valdes
Raghvendra M. Srivastava
Tatiana M. Garcia-Bates
Esperanza Hechavarría
Zuyén González
A. González
Martha Lugiollo
Iván Cuevas
Carlos Frómeta
Braulio F. Mestre
Maria C. Barroso
Tania Crombet
Robert L. Ferris
Show All
Source
Cite
Save
Citations (18)
1